Flagship Pioneering

Actively investingGMP manufacturing

Originate breakthrough platform companies in-house, then capitalize the manufacturing and clinical scale-up required to bring novel modalities (mRNA, genomic medicines) to patients.

VC / Investment firmCambridge, MA, United States$14B AUMWebsite

Open roomCompare

Overview Investment focus Portfolio Team Network Due diligence

Co-investment & syndicate network

Well-connected · 4

Solo / sole investor

Originates and solely funds companies at inception, syndicating only at crossover / IPO stage with public-market investors.

AstraZenecaRecurring

Strategic / Pharma · 2 shared deals

Shared: Moderna collaboration

T. Rowe PriceRecurring

Crossover / Public · 3 shared deals

Shared: Pre-IPO crossover rounds

Fidelity ManagementOccasional

Crossover / Public · 2 shared deals

Shared: Sana, Moderna

Andreessen Horowitz (Bio)Occasional

VC fund · 1 shared deal

Shared: Generate:Biomedicines

Flagship Pioneering

VC / Investment firm · United States

Manufacturing-active

Live record · illustrative seed data · scores deterministic, rules-based — not AI.